Follow-The-Filings

Security

ACRS

Aclaris Therapeutics Inc. · COM

Equity holders as of 2026 Q1 (each manager’s latest book)

9 owners 1 new 1 exit max 0.0% (Dmitry Balyasny - Balyasn...)

grid → activity →
owners 9
max % 0.0%
tracked value $53M
qoq N 1 A 2 R 5 E 1

holders

sorted by % of portfolio · long equity only · exits show last held size

manager % port activity shares value history
Dmitry Balyasny - Balyasny Asset Management L.P. 2026 Q1 0.0% New 0.0% 3,361,328 $13M hist
Vanguard Group Inc. 2025 Q4 stale 0.0% Reduce 0.00 pp 6,502,080 $20M hist
Ken Griffin - Citadel Advisors LLC 2026 Q1 0.0% Add 0.00 pp 2,249,319 $8M hist
D. E. Shaw & Co., Inc. 2026 Q1 0.0% Reduce 0.00 pp 900,804 $3M hist
Israel Englander - Millennium Management LLC 2026 Q1 0.0% Reduce 0.00 pp 756,127 $3M hist
Marshall Wace - Marshall Wace, LLP 2026 Q1 0.0% Add 0.00 pp 712,984 $3M hist
Renaissance Technologies LLC 2026 Q1 0.0% Reduce 0.00 pp 502,631 $2M hist
Two Sigma Investments, LP 2025 Q4 stale 0.0% Exit 0.00 pp 574,213 $2M hist
Cliff Asness - Aqr Capital Management LLC 2026 Q1 0.0% Reduce 0.00 pp 72,408 $272 hist
Steve Cohen - Point72 Asset Management, L.P. exited 2026 Q1 last 2025 Q4 0.0% Exit 0.00 pp 87,175 $262 hist

9 current · 1 exited last period · options excluded

financials

US-GAAP annual · as tagged in Form 10-K · fiscal years · values link to the SEC filing

Income statement

Metric FY2023 FY2024 FY2025
Revenue $31.25M $18.72M $7.83M
Gross profit * $27.83M $15.93M $5.74M
Gross margin * 89.0% 85.1% 73.3%
Net income -$88.48M -$132.06M -$64.92M
Net margin * -283.1% -705.5% -829.6%

Balance sheet

Metric FY2023 FY2024 FY2025
Total current assets $128.86M $125.95M $96.32M
Total non-current assets * $68.55M $94.38M $64.14M
Total assets $197.4M $220.33M $160.46M
Total current liabilities $30.95M $31.6M $28.64M
Total non-current liabilities * $9.27M $33.18M $28.73M
Total equity $157.18M $155.55M $103.08M

Cash flow

Metric FY2023 FY2024 FY2025
Cash from operations -$78.32M -$20.08M -$47.11M
Cash from investing $46.22M -$69.77M $48.36M
Cash from financing $26.71M $74.54M -$5.86M
Net change in cash -$5.4M -$15.31M -$4.61M

Source: SEC companyfacts (US-GAAP 10-K) · * = computed (not a single XBRL tag) · fiscal year as labeled by the issuer · not adjusted or audited by Follow-The-Filings

ownership over time

filing count by report period · click a bar for that quarter’s holders